Jim Simons Indaptus Therapeutics, Inc. Transaction History
Renaissance Technologies LLC
- $63.6 Billion
- Q1 2024
A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Indaptus Therapeutics, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 26,100 shares of INDP stock, worth $56,898. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,100
Previous 29,400
11.22%
Holding current value
$56,898
Previous $52,000
11.54%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding INDP
# of Institutions
18Shares Held
588KCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA256KShares$558,6570.0% of portfolio
-
Investment House LLC Las Vegas, NV102KShares$223,3120.01% of portfolio
-
Geode Capital Management, LLC Boston, MA54.8KShares$119,3920.0% of portfolio
-
Strategy Asset Managers LLC45.3KShares$98,8320.02% of portfolio
-
Pine Valley Investments LTD Liability CO Marlton, NJ44.1KShares$96,2360.01% of portfolio
About Indaptus Therapeutics, Inc.
- Ticker INDP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,258,600
- Market Cap $18M
- Description
- Indaptus Therapeutics, Inc., a pre-clinical biotechnology company, develops various anti-cancer and anti-viral immunotherapy products. Its lead clinical oncology candidate is Decoy20 to single agent activity and/or combination therapy-based durable responses of lymphoma, hepatocellular, colorectal, and pancreatic tumors, as well as hepatitis B v...